Long Island Jewish Medical Center
- Type
- Teaching hospital
- Where
- New Hyde Park, NY
- Medicare CCN
- 330195
- Received
- $292,783 in 70 records, 2021 ($65,510 general, $227,272 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: LONG ISLAND JEWISH MEDICAL CENTER Fuzzy (name and state)
- Business registration: Long Island Jewish Medical Center, Inc Fuzzy (name and state)
- Plan sponsor: LONG ISLAND JEWISH MEDICAL CENTER Fuzzy (name and state)
- Federal award recipient: LONG ISLAND JEWISH MEDICAL CENTER Fuzzy (name and state)
- Federal award recipient: LONG ISLAND JEWISH MEDICAL CENTER Fuzzy (name and state)
- Nonprofit: LONG ISLAND JEWISH MEDICAL CENTER Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2021 | General payment | 56 | $65,510 |
| 2021 | Research payment | 14 | $227,272 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $144,328 | 2021 |
| UCB SA | 7 | $63,742 | 2021 |
| Aesculap Biologics, LLC | 4 | $44,201 | 2021 |
| Abbott Laboratories | 32 | $23,951 | 2021 |
| Smith+Nephew, Inc. | 1 | $9,705 | 2021 |
| Aesculap, Inc. | 2 | $1,268 | 2021 |
| Hill-Rom Company, Inc | 1 | $1,250 | 2021 |
| APPLIED MEDICAL TECHNOLOGY INC | 4 | $1,204 | 2021 |
| LEICA MICROSYSTEMS INC. | 5 | $959 | 2021 |
| Johnson & Johnson Health Care Systems Inc. | 2 | $639 | 2021 |
| Zimmer Biomet Holdings, Inc. | 1 | $475 | 2021 |
| Welch Allyn | 1 | $372 | 2021 |
| Olympus America Inc. | 2 | $281 | 2021 |
| KLS-Martin L.P. | 1 | $208 | 2021 |
| RADIOMETER AMERICA, INC | 1 | $100 | 2021 |
| Cochlear Americas | 2 | $95 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 14 | $227,272 |
| Debt forgiveness | 42 | $36,243 |
| Grant | 1 | $25,000 |
| Space rental or facility fees (teaching hospital only) | 1 | $1,250 |
| Royalty or License | 4 | $1,204 |
| Education | 6 | $1,059 |
| Gift | 2 | $754 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2021-12-21 | Takeda Pharmaceuticals U.S.A., Inc. | $101,140 | Research payment | Cash or cash equivalent | TRINTELLIX Drug, NEUROSCIENCE | Adjunctive Vortioxetine or Placebo for Negative Symptoms and Cognitive Impairment in Schizophrenia | 2021 |
| 2021-12-06 | Johnson & Johnson Health Care Systems Inc. | $50 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-11-30 | KLS-Martin L.P. | $208 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-11-16 | UCB SA | $1,401 | Research payment | Cash or cash equivalent | A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Eff | 2021 | |
| 2021-11-02 | UCB SA | $5,052 | Research payment | Cash or cash equivalent | Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects with Generalized Myasthenia Gravis | 2021 | |
| 2021-10-22 | APPLIED MEDICAL TECHNOLOGY INC | $355 | Royalty or License | Cash or cash equivalent | AMT Bridle Device, Enteral | 2021 | |
| 2021-10-19 | UCB SA | $1,252 | Research payment | Cash or cash equivalent | A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Eff | 2021 | |
| 2021-09-27 | Takeda Pharmaceuticals U.S.A., Inc. | $13,959 | Research payment | In-kind items and services | TRINTELLIX Drug | Adjunctive Vortioxetine or Placebo for Negative Symptoms and Cognitive Impairment in Schizophrenia | 2021 |
| 2021-09-27 | Takeda Pharmaceuticals U.S.A., Inc. | $4,229 | Research payment | In-kind items and services | TRINTELLIX Drug | Adjunctive Vortioxetine or Placebo for Negative Symptoms and Cognitive Impairment in Schizophrenia | 2021 |
| 2021-09-22 | RADIOMETER AMERICA, INC | $100 | Education | In-kind items and services | Plasma/Low Device, Devices | 2021 | |
| 2021-09-20 | Johnson & Johnson Health Care Systems Inc. | $589 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-09-20 | LEICA MICROSYSTEMS INC. | $277 | Education | In-kind items and services | SENTIMAG Device, Devices | 2021 | |
| 2021-09-20 | LEICA MICROSYSTEMS INC. | $277 | Education | In-kind items and services | SENTIMAG Device, Devices | 2021 | |
| 2021-09-20 | LEICA MICROSYSTEMS INC. | $135 | Education | In-kind items and services | SENTIMAG Device, Devices | 2021 | |
| 2021-09-20 | LEICA MICROSYSTEMS INC. | $135 | Education | In-kind items and services | SENTIMAG Device, Devices | 2021 | |
| 2021-09-20 | LEICA MICROSYSTEMS INC. | $135 | Education | In-kind items and services | SENTIMAG Device, Devices | 2021 | |
| 2021-09-10 | Cochlear Americas | $35 | Debt forgiveness | Cash or cash equivalent | Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode Device, Implantable hearing solution | 2021 | |
| 2021-09-07 | Takeda Pharmaceuticals U.S.A., Inc. | $25,000 | Grant | Cash or cash equivalent | 2021 | ||
| 2021-08-31 | Zimmer Biomet Holdings, Inc. | $475 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2021 | |
| 2021-08-20 | Hill-Rom Company, Inc | $1,250 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2021 | ||
| 2021-08-10 | UCB SA | $24,920 | Research payment | Cash or cash equivalent | Phase 3, Multicenter, Randomized, Double-Blind, PBO-Controlled Study of Efficacy, Safety, and Tolerability of Zilucoplan | 2021 | |
| 2021-08-03 | UCB SA | $10,002 | Research payment | Cash or cash equivalent | Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects with Generalized Myasthenia Gravis | 2021 | |
| 2021-08-03 | Aesculap, Inc. | $790 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-08-03 | Aesculap, Inc. | $478 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-07-20 | APPLIED MEDICAL TECHNOLOGY INC | $524 | Royalty or License | Cash or cash equivalent | AMT Bridle Device, Enteral | 2021 | |
| 2021-07-14 | Abbott Laboratories | $307 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-06-28 | Abbott Laboratories | $2,530 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-06-28 | Abbott Laboratories | $1,600 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-06-28 | Abbott Laboratories | $426 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-06-28 | Abbott Laboratories | $250 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-06-18 | Aesculap Biologics, LLC | $11,967 | Research payment | Cash or cash equivalent | NOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION | NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) | 2021 |
| 2021-06-15 | Abbott Laboratories | $1,367 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-05-09 | Smith+Nephew, Inc. | $9,705 | Debt forgiveness | Cash or cash equivalent | R3 Device, Recon Hips | 2021 | |
| 2021-05-04 | UCB SA | $9,363 | Research payment | Cash or cash equivalent | Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects with Generalized Myasthenia Gravis | 2021 | |
| 2021-04-30 | Welch Allyn | $372 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-04-27 | UCB SA | $11,750 | Research payment | Cash or cash equivalent | Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects with Generalized Myasthenia Gravis | 2021 | |
| 2021-04-12 | APPLIED MEDICAL TECHNOLOGY INC | $185 | Royalty or License | Cash or cash equivalent | AMT Bridle Device, Enteral | 2021 | |
| 2021-04-09 | Aesculap Biologics, LLC | $10,083 | Research payment | Cash or cash equivalent | NOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION | NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) | 2021 |
| 2021-02-26 | Aesculap Biologics, LLC | $11,867 | Research payment | Cash or cash equivalent | NOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION | NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) | 2021 |
| 2021-02-23 | Olympus America Inc. | $2 | Debt forgiveness | In-kind items and services | BALLOON3 Device, Gastroenterology | 2021 | |
| 2021-02-12 | Abbott Laboratories | $478 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-02-12 | Abbott Laboratories | $420 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-02-12 | Abbott Laboratories | $380 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-02-12 | Abbott Laboratories | $331 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-02-12 | Abbott Laboratories | $226 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-02-12 | Abbott Laboratories | $218 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-02-12 | Abbott Laboratories | $218 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-02-08 | Cochlear Americas | $60 | Debt forgiveness | Cash or cash equivalent | Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode Device, Implantable hearing solution | 2021 | |
| 2021-01-22 | Aesculap Biologics, LLC | $10,283 | Research payment | Cash or cash equivalent | NOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATION | NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D) | 2021 |
| 2021-01-13 | Abbott Laboratories | $1,370 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Abbott Laboratories | $1,370 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Abbott Laboratories | $1,370 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Abbott Laboratories | $1,370 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Abbott Laboratories | $1,370 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Abbott Laboratories | $1,370 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Abbott Laboratories | $1,324 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Abbott Laboratories | $848 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Abbott Laboratories | $732 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Abbott Laboratories | $732 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Abbott Laboratories | $511 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-12 | APPLIED MEDICAL TECHNOLOGY INC | $138 | Royalty or License | Cash or cash equivalent | AMT Bridle Device, Enteral | 2021 | |
| 2021-01-08 | Abbott Laboratories | $423 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-08 | Abbott Laboratories | $423 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-08 | Abbott Laboratories | $423 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-08 | Abbott Laboratories | $397 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-08 | Abbott Laboratories | $314 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-08 | Abbott Laboratories | $300 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-08 | Abbott Laboratories | $272 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-08 | Abbott Laboratories | $263 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-01-01 | Olympus America Inc. | $279 | Gift | In-kind items and services | Olympus Device, Energy | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In New Hyde Park, NY, county Nassau County, NY, state New York; placed by its city name.
| Measure | Place (city or town) New Hyde Park, NY | County Nassau County, NY | State New York |
|---|---|---|---|
| Population B01003 | 10,220 | 1,389,591 | 19,852,366 |
| Population, 2020 census P1 | 10,257 | 1,395,774 | 20,201,249 |
| Median age B01002 | 43.2 | 42.0 | 39.8 |
| Under 18 B01001 | 18.7% | 21.5% | 20.5% |
| 65 and over B01001 | 19.2% | 18.7% | 17.9% |
| Households B11001 | 3,534 | 458,166 | 7,722,646 |
| Foreign born B05002 | 30.9% | 23.3% | 22.8% |
| Median household income B19013 | $142,927 | $146,202 | $85,974 |
| Median family income B19113 | $161,042 | $169,137 | $106,873 |
| Per capita income B19301 | $64,210 | $64,198 | $50,712 |
| Poverty rate B17001 | 3.6% | 5.4% | 14.0% |
| Unemployment rate B23025 | 4.9% | 4.8% | 6.4% |
| Civilian labor force B23025 | 5,741 | 730,034 | 10,171,766 |
| Mean commute (minutes) B08013 | 37.9 | 36.0 | 32.6 |
| Bachelor's degree or higher B15003 | 48.4% | 49.7% | 40.2% |
| Housing units B25001 | 3,678 | 479,044 | 8,585,241 |
| Owner-occupied B25003 | 86.9% | 81.9% | 54.3% |
| Renters B25003 | 13.1% | 18.1% | 45.7% |
| Median home value B25077 | $722,900 | $684,700 | $423,800 |
| Median gross rent B25064 | $2,172 | $2,252 | $1,621 |
| White, not Hispanic B03002 | 48.9% | 54.3% | 52.8% |
| Black B03002 | 1.9% | 10.8% | 13.4% |
| Hispanic or Latino B03002 | 9.4% | 18.7% | 19.8% |
| Asian B03002 | 34.2% | 12.2% | 9.0% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in New Hyde Park, NY.
Comments